News

The Albanese government has announced an expansion to treatment options under the Pharmaceutical Benefits Scheme (PBS), amid ...
Two new regimens look set to transform treatment to delay melanoma returning in patients after surgery. Results from Bristol-Myers Squibb’s Opdivo and Novartis' Tafinlar plus Mekinst were ...